|
1
|
Chowdhury UK, Sathia S, Ray R, Singh R,
Pradeep KK and Venugopal P: Histopathology of the right ventricular
outflow tract and its relationship to clinical outcomes and
arrhythmias in patients with tetralogy of Fallot. J Thorac
Cardiovasc Surg. 132:270–277. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Higgins DF, Kimura K, Iwano M and Haase
VH: Hypoxia-inducible factor signaling in the development of tissue
fibrosis. Cell Cycle. 7:1128–1132. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fan D, Takawale A, Lee J and Kassiri Z:
Cardiac fibroblasts, fibrosis and extracellular matrix remodeling
in heart disease. Fibrogenesis Tissue Repair. 5:152012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Greco S, Gorospe M and Martelli F:
Noncoding RNA in age-related cardiovascular diseases. J Mol Cell
Cardiol. 83:142–155. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Condorelli G, Latronico MV and Cavarretta
E: microRNAs in cardiovascular diseases: Current knowledge and the
road ahead. J Am Coll Cardiol. 63:2177–2187. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Smith T, Rajakaruna C, Caputo M and
Emanueli C: MicroRNAs in congenital heart disease. Ann Transl Med.
3:3332015.PubMed/NCBI
|
|
7
|
van Rooij E, Sutherland LB, Thatcher JE,
DiMaio JM, Naseem RH, Marshall WS, Hill JA and Olson EN:
Dysregulation of microRNAs after myocardial infarction reveals a
role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA.
105:13027–13032. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Archer K, Broskova Z, Bayoumi AS, Teoh JP,
Davila A, Tang Y, Su H and Kim IM: Long non-coding RNAs as master
regulators in cardiovascular diseases. Int J Mol Sci.
16:23651–23667. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schonrock N, Harvey RP and Mattick JS:
Long noncoding RNAs in cardiac development and pathophysiology.
Circ Res. 111:1349–1362. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang K, Liu F, Zhou LY, Long B, Yuan SM,
Wang Y, Liu CY, Sun T, Zhang XJ and Li PF: The long noncoding RNA
CHRF regulates cardiac hypertrophy by targeting miR-489. Circ Res.
114:1377–1388. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Watson CJ, Collier P, Tea I, Neary R,
Watson JA, Robinson C, Phelan D, Ledwidge MT, McDonald KM, McCann
A, et al: Hypoxia-induced epigenetic modifications are associated
with cardiac tissue fibrosis and the development of a
myofibroblast-like phenotype. Hum Mol Genet. 23:2176–2188. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chang YN, Zhang K, Hu ZM, Qi HX, Shi ZM,
Han XH, Han YW and Hong W: Hypoxia-regulated lncRNAs in cancer.
Gene. 575:1–8. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xie S, Chen H, Li F, Wang S and Guo J:
Hypoxia-induced microRNA-155 promotes fibrosis in proximal tubule
cells. Mol Med Rep. 11:4555–4560. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu M, Liu L, Bai M, Zhang L, Ma F, Yang X
and Sun S: Hypoxia-induced activation of Twist/miR-214/E-cadherin
axis promotes renal tubular epithelial cell mesenchymal transition
and renal fibrosis. Biochem Biophys Res Commun. 495:2324–2330.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang QQ, Xu MY, Qu Y, Hu JJ, Li ZH, Zhang
QD and Lu LG: TET3 mediates the activation of human hepatic
stellate cells via modulating the expression of long non-coding RNA
HIF1A-AS1. Int J Clin Exp Pathol. 7:7744–7751. 2014.PubMed/NCBI
|
|
17
|
Liu Y, Li Y, Xu Q, Yao W, Wu Q, Yuan J,
Yan W, Xu T, Ji X and Ni C: Long non-coding RNA-ATB promotes EMT
during silica-induced pulmonary fibrosis by competitively binding
miR-200c. Biochim Biophys Acta. 1864:420–431. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nagpal V, Rai R, Place AT, Murphy SB,
Verma SK, Ghosh AK and Vaughan DE: MiR-125b is critical for
fibroblast-to-myofibroblast transition and cardiac fibrosis.
Circulation. 133:291–301. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang J, Chang JJ, Xu F, Ma XJ, Wu Y, Li
WC, Wang HJ, Huang GY and Ma D: MicroRNA deregulation in right
ventricular outflow tract myocardium in nonsyndromic tetralogy of
fallot. Can J Cardiol. 29:1695–1703. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Poliseno L, Salmena L, Zhang J, Carver B,
Haveman WJ and Pandolfi PP: A coding-independent function of gene
and pseudogene mRNAs regulates tumour biology. Nature.
465:1033–1038. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roncarati R, Anselmi Viviani C, Losi MA,
Papa L, Cavarretta E, Da Costa Martins P, Contaldi C, Saccani Jotti
G, Franzone A, Galastri L, et al: Circulating miR-29a, among other
up-regulated microRNAs, is the only biomarker for both hypertrophy
and fibrosis in patients with hypertrophic cardiomyopathy. J Am
Coll Cardiol. 63:920–927. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang HW, Wang EW, Li LX, Yi SH, Li LC, Xu
FL, Wang DL, Wu YZ and Nian WQ: A regulatory loop involving miR-29c
and Sp1 elevates the TGF-β1 mediated epithelial-to-mesenchymal
transition in lung cancer. Oncotarget. 7:85905–85916.
2016.PubMed/NCBI
|
|
23
|
Wang JH, Zhao L, Pan X, Chen NN, Chen J,
Gong QL, Su F, Yan J, Zhang Y and Zhang SH: Hypoxia-stimulated
cardiac fibroblast production of IL-6 promotes myocardial fibrosis
via the TGF-β1 signaling pathway. Lab Invest. 96:839–852. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pedroza M, Le TT, Lewis K,
Karmouty-Quintana H, To S, George AT, Blackburn MR, Tweardy DJ and
Agarwal SK: STAT-3 contributes to pulmonary fibrosis through
epithelial injury and fibroblast-myofibroblast differentiation.
FASEB J. 30:129–140. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Baumann B, Hayashida T, Liang X and
Schnaper HW: Hypoxia-inducible factor-1α promotes
glomerulosclerosis and regulates COL1A2 expression through
interactions with Smad3. Kidney Int. 90:797–808. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Klattenhoff CA, Scheuermann JC, Surface
LE, Bradley RK, Fields PA, Steinhauser ML, Ding H, Butty VL, Torrey
L, Haas S, et al: Braveheart, a long noncoding RNA required for
cardiovascular lineage commitment. Cell. 152:570–583. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kumarswamy R, Bauters C, Volkmann I, Maury
F, Fetisch J, Holzmann A, Lemesle G, de Groote P, Pinet F and Thum
T: Circulating long noncoding RNA, LIPCAR, predicts survival in
patients with heart failure. Circ Res. 114:1569–1575. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Young TL, Matsuda T and Cepko CL: The
noncoding RNA taurine upregulated gene 1 is required for
differentiation of the murine retina. Curr Biol. 15:501–512. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liang S, Zhang S, Wang P, Yang C, Shang C,
Yang J and Wang J: LncRNA, TUG1 regulates the oral squamous cell
carcinoma progression possibly via interacting with Wnt/β-catenin
signaling. Gene. 608:49–57. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang L, Cheng H, Yue Y, Li S, Zhang D and
He R: TUG1 knockdown ameliorates atherosclerosis via up-regulating
the expression of miR-133a target gene FGF1. Cardiovasc Pathol.
33:6–15. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Michalik KM, You X, Manavski Y,
Doddaballapur A, Zörnig M, Braun T, John D, Ponomareva Y, Chen W,
Uchida S, et al: Long noncoding RNA MALAT1 regulates endothelial
cell function and vessel growth. Circ Res. 114:1389–1397. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
He Q, Yang S, Gu X, Li M, Wang C and Wei
F: Long noncoding RNA TUG1 facilitates osteogenic differentiation
of periodontal ligament stem cells via interacting with Lin28A.
Cell Death Dis. 9:4552018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang E, He X, Yin D, Han L, Qiu M, Xu T,
Xia R, Xu L, Yin R and De W: Increased expression of long noncoding
RNA TUG1 predicts a poor prognosis of gastric cancer and regulates
cell proliferation by epigenetically silencing of p57. Cell Death
Dis. 7:e21092016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yu C, Li L, Xie F, et al: LncRNA TUG1
sponges miR-204-5p to promote osteoblast differentiation through
upregulating Runx2 in aortic valve calcification. Cardiovasc Res.
114:168–179. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A
long noncoding RNA controls muscle differentiation by functioning
as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tang W, Shen Z, Guo J and Sun S: Screening
of long non-coding RNA and TUG1 inhibits proliferation with TGF-β
induction in patients with COPD. Int J Chron Obstruct Pulmon Dis.
11:2951–2964. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fang Y, Yu X, Liu Y, Kriegel AJ, Heng Y,
Xu X, Liang M and Ding X: miR-29c is downregulated in renal
interstitial fibrosis in humans and rats and restored by HIF-α
activation. Am J Physiol Renal Physiol. 304:F1274–F1282. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Khalil W, Xia H, Bodempudi V, Kahm J,
Hergert P, Smith K, Peterson M, Parker M, Herrera J, Bitterman PB
and Henke CA: Pathologic regulation of collagen I by an aberrant
protein phosphatase 2A/histone deacetylase C4/MicroRNA-29 signal
axis in idiopathic pulmonary fibrosis fibroblasts. Am J Respir Cell
Mol Biol. 53:391–399. 2015. View Article : Google Scholar : PubMed/NCBI
|
